CLINOVATE 2027 – Precision & Molecular Diagnostics
14th International Health Dialogue | 29–30 January 2027
Step into the evolving world of precision and molecular diagnostics at CLINOVATE 2027, bringing together clinicians, laboratory specialists, researchers and healthcare experts to explore the changing role of diagnostics in patient care. Through engaging panel discussions and evidence-led perspectives, the conference will examine biomarker-driven cancer care, early detection of Alzheimer’s disease, HPV-based cervical cancer screening, molecular testing in transplantation and the opportunities and limitations of multicancer detection assays.
- Expert Perspectives Across Specialties
Explore multidisciplinary perspectives across oncology, neurology, cervical cancer screening, transplantation and laboratory medicine, with a focus on connecting diagnostic advances to clinical decision-making.
- Thought-Provoking Panel Discussions
Engage with critical questions shaping modern diagnostics: Can every tumour be treated differently? Can Alzheimer’s disease be detected before symptoms appear? Can HPV testing close India’s cervical cancer screening gap? How is molecular testing reshaping transplant care—and what can multicancer detection assays realistically deliver?
- Evidence-Led Insights into Diagnostic Innovation
Examine the evidence, validation requirements and clinical considerations surrounding emerging diagnostic tools. Explore early diagnosis pathways, screening access, multidisciplinary decision-making and the importance of India-specific data.
Program Highlights:
Precision Oncology: Can We Truly Treat Every Tumour Differently?
Explore biomarker-driven treatment, next-generation sequencing and companion diagnostics. Examine the role of molecular tumour boards and multidisciplinary decision-making in translating molecular findings into personalised cancer care.
Neurodegenerative Disorders: Can We Catch Alzheimer’s Before Symptoms Appear?
Discover the evolving role of blood-based biomarkers, amyloid assessment and PET imaging in Alzheimer’s disease evaluation. Discuss early diagnosis pathways and their implications for dementia prevention and care.
Cervical Cancer Screening: Can HPV Testing Close India’s Screening Gap?
Examine HPV DNA testing alongside Pap smear and visual inspection with acetic acid (VIA). Explore self-sampling, access, screening at scale and integration with maternal health services.
Molecular Diagnostics in Transplantation: How Is Testing Reshaping Transplant Care?
Explore the role of molecular diagnostics in transplant workup and follow-up, including HLA typing and matching, donor-derived cell-free DNA, rejection surveillance and post-transplant monitoring.
Multicancer Detection Assays: Opportunities and Limitations
Examine the promise and limitations of blood-based multicancer detection. Discuss evidence and validation, sensitivity and false-positive results, and the need for India-specific data to assess their potential role in cancer screening.